Papillary thyroid cancer
Definition: A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance. Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy. Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.
Synonyms (terms occurring on more labels are shown first): papillary thyroid carcinoma, papillary thyroid cancer
More information: PubMed search and possibly Wikipedia
Drugs with this side effect as MedDRA Preferred Term
|
License: Except as otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 4.0 License. For commercial use or customized versions, please contact biobyte solutions GmbH.
Disclaimer: The content of this database of side effects (adverse drug reactions) is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.